South Texas Accelerated Research Therapeutics (START)-Midwest — Grand Rapids, Michigan

South Texas Accelerated Research Therapeutics (START)-Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49503.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics (START)-Midwest has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors, Multiple Myeloma, Non-Hodgkins Lymphoma.

Sponsors: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics (START)-Midwest?

South Texas Accelerated Research Therapeutics (START)-Midwest has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics (START)-Midwest conducted?

South Texas Accelerated Research Therapeutics (START)-Midwest has 1 clinical trials on record. Their work covers Solid Tumors, Multiple Myeloma, Non-Hodgkins Lymphoma.

Is South Texas Accelerated Research Therapeutics (START)-Midwest accredited by Crixeo Health?

South Texas Accelerated Research Therapeutics (START)-Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics (START)-Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.